Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

The International Journal of Tuberculosis and Lung Disease

ISSN:
1027-3719
2
h-index
9
Citations
6
Works

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
0101345201420152016201820202022202320242014: Publications 1, Citations 02015: Publications 1, Citations 02016: Publications 1, Citations 12018: Publications 1, Citations 02020: Publications 0, Citations 22022: Publications 1, Citations 02023: Publications 1, Citations 12024: Publications 0, Citations 5

Citation history

01345201420152016201820202022202320242014: Citations 02015: Citations 02016: Citations 12018: Citations 02020: Citations 22022: Citations 02023: Citations 12024: Citations 5

Publication history

01201420152016201820202022202320242014: Publications 12015: Publications 12016: Publications 12018: Publications 12020: Publications 02022: Publications 12023: Publications 12024: Publications 0

h-index evolution

Cumulative h-index by year

012201420152016201820202022202320242014: h-index 02015: h-index 02016: h-index 12018: h-index 12020: h-index 12022: h-index 12023: h-index 12024: h-index 2

Most-cited works

  1. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan20223 citations
  2. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan20162 citations
  3. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms20142 citations
  4. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 citations
  5. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan20231 citations
  6. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study20150 citations
View in AkademIndex →